Merck Vioxx recall: analyst, investor reaction
241280
Merck &amp; Co. (MRK.N: Quote, Profile, Research) on Thursday withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
350800
NEW YORK, Nov. 11 -- The 40 percent share price slide in Merck &#38; Co. in the five weeks after it pulled the painkiller Vioxx off the market highlighted larger problems in the pharmaceutical industry that may depress performance for years, according to academics and stock analysts who follow the sector.
467183
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
467982
&#151; Merck & Co., the US drug maker that recalled its Vioxx painkiller because of a link to heart disease, said short-term studies show the company's planned successor pill, Arcoxia, is safer.
205489
NEW YORK - Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets because of severe side effects left the pharmaceutical sector mixed Thursday.
172863
US stocks futures tumbled on Thursday after drug company Merck &amp; Co. (MRK.N: Quote, Profile, Research) announced it was recalling a key drug, indicating the market would open lower.
145358
Merck said lost Vioxx sales and estimated customer returns totaled $492 million in the third quarter, and the recall slashed net income by about $553 million.
320680
Pharmaceutical titan Merck &amp; Co. Inc. yesterday pulled its blockbuster arthritis drug Vioxx off the market, citing safety concerns, thereby triggering a massive selloff in the company&#39;s shares that wiped out nearly US$27-billion of Merck&#39;s market value.
428395
Merck & Co Inc. is evaluating why its withdrawn painkiller Vioxx raises the chance of heart attack and stroke, but it has not found a mechanism of action, a company official said on Monday.
540524
(CBS) When the pharmaceutical giant Merck pulled its blockbuster pain medication Vioxx off the market in late September, it became the largest prescription drug recall in history.
496967
The House Energy and Commerce Committee is investigating how Vioxx was approved and then taken off the market. It has written to Lester Crawford, FDA, and Ray Gilmartin, CEO of Merck, requesting documents about Vioxx.
9199
Merck &amp; Co. Inc. has been in crisis since Sept. 30, when the company pulled its prescription painkiller Vioxx off the market after a study confirmed the drug increased the risk of heart attack and stroke. Merck chief Raymond Gilmar tin is grappling with multiple product-liability and shareholder lawsuits. Scheduled to retire in April 2006 under a plan in place ...
328935
SOME of the biggest companies in the drug industry are shivering under an avalanche of bad news. Merck has already been hit hard by the withdrawal of Vioxx, its arthritis drug.
415386
The recall of Merck&#39;s arthritis drug Vioxx has drawn attention to drug overall safety, more specifically, a similar drug known as Celebrex, by the drug maker Pfizer.
51395
Merck &amp; Co. withdrew the popular drug Vioxx from the market in September, after data from a clinical trial supported claims the medication was associated with an increased risk of heart attack and stroke.
506626
Merck pulled Vioxx from the market on September 30th, saying it was acting in the best interest of patients. But internal documents reportedly show the company knew as far back as 2000 that